Skagit Valley Hospital Standardizes on Masimo SET® Measure-Through
Motion and Low Perfusion Pulse Oximetry
MOUNT VERNON, Wash. and
IRVINE, Calif., Nov. 6, 2012 /PRNewswire/ -- Skagit Valley
Hospital, among the Top 100 in 2012 for joint replacement,
orthopedics and prostatectomy, according to health care ratings
firm HealthGrades, and Masimo (NASDAQ: MASI) today announced the
hospital's system-wide standardization to Masimo SET®
Pulse Oximetry.
Skagit Valley Hospital will standardize on SET® pulse
oximetry technology at every patient bed and in every care
area(monitors and sensors), creating an environment that provides
Skagit Valley Hospital clinicians with accurate patient
monitoring capabilities during challenging conditions, including
patient movement and low perfusion.
"Skagit Valley Hospital is dedicated to providing safe, quality
care to our patients. We are pleased to continue to bring in the
latest in technology to benefit the patients we serve," said
Getty Phippen, Skagit Valley
Hospital Director of Pulmonary and Sleep Services. "Masimo's
technology is excellent and the monitors are precise, picking
up signals even when patients' hands are cold."
Skagit Valley Hospital will also deploy rainbow®
Acoustic Monitoring for acoustic respiration rate (RRa™), which
noninvasively and continuously measures respiration rate using an
innovative adhesive sensor with an integrated acoustic transducer
that is easily and comfortably applied to the patient's neck. RRa
is a breakthrough measurement that facilitates earlier detection of
respiratory compromise and patient distress – especially important
for post-surgical patients receiving patient-controlled analgesia
for pain management, as the sedation can induce respiratory
depression and place patients at considerable risk of serious
injury or death.1-3
"We compared Masimo to others and found Masimo's technology
works better, especially when patients moved around a lot," said
Bill Thomas, Materials Management
Director at Skagit Valley Hospital. "We're happy with the product
and it cost less. So, we're saving money and getting a
better outcome for our patients. It was a win-win."
"This partnership with Skagit Valley Hospital is another example
of a leading healthcare organization improving patient outcomes
with Masimo SET® technology," said Joe Kiani, chairman and CEO of Masimo. "Patient
care and safety remain our top priority, and we're happy that
our technology will help Skagit Valley Hospital keep continuous and
noninvasive watch over their patients, whether in the OR or on the
general floor."
Masimo SET® virtually eliminates false
alarms4 and helps clinicians detect life-threatening
events.5 More than 100 independent clinical studies have
confirmed that Masimo SET® technology allows clinicians
to accurately monitor blood oxygen saturation in the most
challenging conditions – helping to substantially contribute to
improved patient outcomes. The option to upgrade to Masimo
rainbow® SET® Pulse CO-Oximetry allows
clinicians to noninvasively monitor multiple blood constituents
that previously required invasive or complicated procedures,
including total hemoglobin (SpHb®), oxygen content
(SpOC™), carboxyhemoglobin (SpCO®), methemoglobin
(SpMet®), Pleth Variability Index (PVI®), and
acoustic respiration rate (RRa).
1 The Joint Commission. Sentinel event alert: Safe use of
opioids in hospitals; 2012.
2 Institute for Safe Medication Practices. Safety issues with
patient-controlled analgesia: Part I – How errors occur; ISMP.
2003.
3 Bird M. Acute pain management: a new area of liability for
anesthesiologists; ASA Newsletter. 2007; 71:8.
4 Shah N, Ragaswamy H, Govindugari K, Estanol L. "Performance of
three new-generation pulse oximeters during motion and low
perfusion in volunteers." Journal of Clinical
Anesthesia. 2012 (10.1016/j.jclinane.2011.10.012) Available
online here
5 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike,
George T. "Impact of Pulse Oximetry Surveillance on Rescue Events
and Intensive Care Unit Transfers: A Before-and-After Concurrence
Study." Anesthesiology, February
2010, Vol. 112, Issue 2. Available
online here
About Skagit Valley Hospital
Licensed for 137 beds, Skagit Valley Hospital is a regional, public
facility serving residents of Skagit, Island, San
Juan and north Snohomish
counties since 1958. The Mount
Vernon hospital and Skagit Regional Clinics, with eight
locations, are part of the integrated system known as Skagit
Regional Health. The hospital's comprehensive services include the
Skagit Regional Heart & Vascular Institute, a Level III Trauma
Center, a comprehensive Regional Cancer Care Center, the
well-appointed Family Birth Center and surgical services with a
focus on orthopedics and minimally invasive procedures. For more
information, visit http://www.skagitvalleyhospital.org/.
About Masimo
Masimo (NASDAQ: MASI) is the global
leader in innovative noninvasive monitoring technologies that
significantly improve patient care—helping solve "unsolvable"
problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET®,
which virtually eliminated false alarms and increased pulse
oximetry's ability to detect life-threatening events. More than 100
independent and objective studies have shown that Masimo
SET® outperforms other pulse oximetry technologies, even
under challenging clinical conditions, including patient motion and
low peripheral perfusion. In 2005, Masimo introduced rainbow
SET® Pulse CO-Oximetry technology, allowing noninvasive
and continuous monitoring of blood constituents that previously
required invasive procedures, including total hemoglobin
(SpHb®), oxygen content (SpOCTM),
carboxyhemoglobin (SpCO®), methemoglobin
(SpMet®), and Pleth Variability Index (PVI®),
in addition to SpO2, pulse rate, and perfusion index
(PI). Additional information about Masimo and its products may be
found at www.masimo.com.
Forward-Looking Statements
This press release
includes forward-looking statements as defined in Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, in connection with the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are
based on current expectations about future events affecting us and
are subject to risks and uncertainties, all of which are difficult
to predict and many of which are beyond our control and could cause
our actual results to differ materially and adversely from those
expressed in our forward-looking statements as a result of various
risk factors, including, but not limited to: risks related to our
assumptions regarding the repeatability of clinical results; risks
related to our belief that Masimo's unique noninvasive measurement
technologies, including: total hemoglobin (SpHb), SpOC, SpCO,
SpMet, PVI, and RRa, contribute to positive clinical outcomes and
patient safety; risks related to our belief that Masimo noninvasive
medical breakthroughs provide cost-effective solutions with
comparable accuracy and unique advantages, including: immediate and
continuous results that enable earlier treatment without causing
invasive trauma in all patients and in every clinical situation; as
well as other factors discussed in the "Risk Factors" section of
our most recent reports filed with the Securities and Exchange
Commission ("SEC"), which may be obtained for free at the
SEC's website at www.sec.gov. Although we believe that the
expectations reflected in our forward-looking statements are
reasonable, we do not know whether our expectations will prove
correct. All forward-looking statements included in this press
release are expressly qualified in their entirety by the foregoing
cautionary statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of today's date. We do not undertake any obligation to update,
amend or clarify these statements or the "Risk Factors" contained
in our most recent reports filed with the SEC, whether as a result
of new information, future events or otherwise, except as may be
required under the applicable securities laws.
Media
Contacts:
|
|
Kari
Ranten
|
Mike
Drummond
|
Skagit
Regional
Health
|
Masimo
Corporation
|
Phone:
(360) 814-2370
|
Phone:
(949) 297-7434
|
Email:kranten@skagitvalleyhospital.org
|
Email:
mdrummond@masimo.com
|
Masimo, SET, Signal Extraction Technology, Improving Patient
Outcome and Reducing Cost of Care... by Taking Noninvasive
Monitoring to New Sites and Applications, rainbow, SpHb, SpOC,
SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7,
Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter,
Adaptive Threshold Alarm, and SEDLine are trademarks or registered
trademarks of Masimo Corporation. The use of the trademarks Patient
SafetyNet and PSN is under license from University HealthSystem
Consortium.
SOURCE Masimo